TreeWAS – Variant ID: rs11644601

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N20 Calculus of kidney and ureter	0.000	0.375	0.625
N20.1 Calculus of ureter	0.000	0.376	0.624
N20.0 Calculus of kidney	0.000	0.403	0.597
N20.9 Urinary calculus, unspecified	0.000	0.431	0.569
N20-N23 Urolithiasis	0.000	0.445	0.555
N23 Unspecified renal colic	0.000	0.461	0.539
N20.2 Calculus of kidney with calculus of ureter	0.000	0.472	0.528
N21 Calculus of lower urinary tract	0.000	0.578	0.421
N22 Calculus of urinary tract in diseases classified elsewhere	0.000	0.602	0.398
N21.0 Calculus in bladder	0.000	0.654	0.346
N21.1 Calculus in urethra	0.000	0.697	0.303
N21.9 Calculus of lower urinary tract, unspecified	0.000	0.698	0.302
N22.8 Calculus of urinary tract in other diseases classified elsewhere	0.000	0.714	0.285
N22.0 Calculus of urinary tract in schistosomiasis [bilharziasis]	0.000	0.714	0.285
N21.8 Other lower urinary tract calculus	0.000	0.731	0.269
D25.9 Leiomyoma of uterus, unspecified	0.000	0.964	0.036
H16.9 Keratitis, unspecified	0.026	0.974	0.000
H16 Keratitis	0.025	0.975	0.000
H16.2 Keratoconjunctivitis	0.024	0.976	0.000
H16.0 Corneal ulcer	0.022	0.978	0.000
H16.8 Other keratitis	0.019	0.981	0.000
H16.4 Corneal neovascularisation	0.019	0.981	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.019	0.981	0.000
H16.3 Interstitial and deep keratitis	0.018	0.981	0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.017	0.983	0.000
J31.0 Chronic rhinitis	0.000	0.984	0.016
R10.4 Other and unspecified abdominal pain	0.000	0.985	0.015
D12.4 Descending colon	0.000	0.986	0.014
H15 Disorders of sclera	0.014	0.986	0.000
H20 Iridocyclitis	0.014	0.986	0.000
K09.0 Developmental odontogenic cysts	0.013	0.987	0.000
H20.9 Iridocyclitis, unspecified	0.013	0.987	0.000
I65.2 Occlusion and stenosis of carotid artery	0.000	0.987	0.013
D16.4 Bones of skull and face	0.013	0.987	0.000
H17 Corneal scars and opacities	0.012	0.987	0.000
H21 Other disorders of iris and ciliary body	0.012	0.988	0.000
J92.0 Pleural plaque with presence of asbestos	0.000	0.988	0.012
A63.0 Anogenital (venereal) warts	0.012	0.988	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.012	0.988	0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.012	0.988	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.012	0.988	0.000
H15.8 Other disorders of sclera	0.012	0.988	0.000
H18 Other disorders of cornea	0.011	0.989	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.011	0.989	0.000
H15.1 Episcleritis	0.011	0.989	0.000
H20.0 Acute and subacute iridocyclitis	0.011	0.989	0.000
H18.9 Disorder of cornea, unspecified	0.011	0.989	0.000
D16 Benign neoplasm of bone and articular cartilage	0.010	0.990	0.000
H17.9 Corneal scar and opacity, unspecified	0.010	0.990	0.000
H15.9 Disorder of sclera, unspecified	0.010	0.990	0.000
H20.2 Lens-induced iridocyclitis	0.010	0.990	0.000
H21.4 Pupillary membranes	0.010	0.990	0.000
H15.0 Scleritis	0.009	0.991	0.000
H17.1 Other central corneal opacity	0.009	0.991	0.000
H17.0 Adherent leukoma	0.009	0.991	0.000
D16.0 Scapula and long bones of upper limb	0.009	0.991	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.009	0.991	0.000
K09 Cysts of oral region, not elsewhere classified	0.009	0.991	0.000
H18.3 Changes in corneal membranes	0.009	0.991	0.000
K62.9 Disease of anus and rectum, unspecified	0.000	0.991	0.009
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.009	0.991	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.009	0.991	0.000
H18.7 Other corneal deformities	0.009	0.991	0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.009	0.991	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.009	0.991	0.000
H20.8 Other iridocyclitis	0.009	0.991	0.000
H22.1 Iridocyclitis in other diseases classified elsewhere	0.009	0.991	0.000
D16.1 Short bones of upper limb	0.009	0.991	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.991	0.009
H18.5 Hereditary corneal dystrophies	0.009	0.991	0.000
L29.0 Pruritus ani	0.009	0.991	0.000
H18.2 Other corneal oedema	0.009	0.991	0.000
K09.8 Other cysts of oral region, not elsewhere classified	0.009	0.991	0.000
H21.1 Other vascular disorders of iris and ciliary body	0.009	0.991	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.991	0.009
H21.2 Degeneration of iris and ciliary body	0.009	0.991	0.000
D16.2 Long bones of lower limb	0.009	0.991	0.000
H18.8 Other specified disorders of cornea	0.008	0.991	0.000
H17.8 Other corneal scars and opacities	0.008	0.992	0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.000	0.992	0.008
K09.2 Other cysts of jaw	0.008	0.992	0.000
D16.3 Short bones of lower limb	0.008	0.992	0.000
D05.1 Intraductal carcinoma in situ	0.000	0.992	0.008
J92 Pleural plaque	0.000	0.992	0.008
D16.5 Lower jaw bone	0.008	0.992	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.008	0.992	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.992	0.008
N63 Unspecified lump in breast	0.000	0.992	0.008
D16.8 Pelvic bones, sacrum and coccyx	0.008	0.992	0.000
D16.7 Ribs, sternum and clavicle	0.008	0.992	0.000
D16.6 Vertebral column	0.008	0.992	0.000
H21.8 Other specified disorders of iris and ciliary body	0.008	0.992	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.992	0.008
H21.0 Hyphaema	0.007	0.993	0.000
N64.1 Fat necrosis of breast	0.000	0.993	0.007
H18.0 Corneal pigmentations and deposits	0.007	0.993	0.000
H20.1 Chronic iridocyclitis	0.007	0.993	0.000
J92.9 Pleural plaque without asbestos	0.000	0.993	0.007
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.007	0.993	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.993	0.007
H18.1 Bullous keratopathy	0.007	0.993	0.000
H18.4 Corneal degeneration	0.007	0.993	0.000
D16.9 Bone and articular cartilage, unspecified	0.006	0.993	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.993	0.006
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.993	0.006
K09.9 Cyst of oral region, unspecified	0.006	0.994	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.994	0.006
N64 Other disorders of breast	0.000	0.994	0.006
N64.4 Mastodynia	0.000	0.994	0.006
T43.6 Psychostimulants with abuse potential	0.000	0.994	0.006
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.000	0.994	0.006
H18.6 Keratoconus	0.005	0.994	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.005	0.994	0.001
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.994	0.006
A63.8 Other specified predominantly sexually transmitted diseases	0.005	0.995	0.000
K09.1 Developmental (nonodontogenic) cysts of oral region	0.005	0.995	0.000
T51.0 Ethanol	0.000	0.995	0.005
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.995	0.005
N61 Inflammatory disorders of breast	0.000	0.995	0.005
N60-N64 Disorders of breast	0.000	0.995	0.005
W22.9 Unspecified place	0.000	0.995	0.005
G55.2 Nerve root and plexus compressions in spondylosis	0.000	0.995	0.005
O26.9 Pregnancy-related condition, unspecified	0.005	0.995	0.000
L29 Pruritus	0.005	0.995	0.000
N64.5 Other signs and symptoms in breast	0.000	0.995	0.005
T45.5 Anticoagulants	0.000	0.995	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.995	0.005
N64.3 Galactorrhoea not associated with childbirth	0.000	0.995	0.004
N64.0 Fissure and fistula of nipple	0.000	0.995	0.004
O14.9 Preeclampsia, unspecified	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.996	0.004
W22 Striking against or struck by other objects	0.000	0.996	0.004
W22.2 School, other institution and public administrative area	0.000	0.996	0.004
J31.1 Chronic nasopharyngitis	0.000	0.996	0.004
Z09.7 Follow-up examination after combined treatment for other conditions	0.004	0.996	0.000
E86 Volume depletion	0.004	0.996	0.000
R39.8 Other and unspecified symptoms and signs involving the urinary system	0.000	0.996	0.004
L29.3 Anogenital pruritus, unspecified	0.004	0.996	0.000
Z93.2 Ileostomy status	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.996	0.004
T45.8 Other primarily systemic and haematological agents	0.000	0.996	0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.004
T45.6 Fibrinolysis-affecting drugs	0.000	0.996	0.004
T45.4 Iron and its compounds	0.000	0.996	0.004
T45.3 Enzymes, not elsewhere classified	0.000	0.996	0.004
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.996	0.004
K92.1 Melaena	0.000	0.996	0.004
L29.8 Other pruritus	0.004	0.996	0.000
C09.9 Tonsil, unspecified	0.000	0.996	0.004
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.000	0.996	0.004
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.996	0.004
N64.2 Atrophy of breast	0.000	0.996	0.004
N64.8 Other specified disorders of breast	0.000	0.996	0.004
K60.2 Anal fissure, unspecified	0.000	0.996	0.004
T39.1 4-Aminophenol derivatives	0.000	0.996	0.004
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.000	0.996	0.004
J31.2 Chronic pharyngitis	0.000	0.996	0.004
C19 Malignant neoplasm of rectosigmoid junction	0.004	0.996	0.000
W23.4 Street and highway	0.000	0.996	0.004
L29.1 Pruritus scroti	0.004	0.996	0.000
M54.39 Sciatica (Site unspecified)	0.000	0.996	0.004
W23 Caught, crushed, jammed or pinched in or between objects	0.000	0.996	0.004
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.996	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.003
L29.9 Pruritus, unspecified	0.003	0.996	0.000
W22.3 Sports and athletics area	0.000	0.996	0.003
W22.8 Other specified place	0.000	0.997	0.003
W22.6 Industrial and construction area	0.000	0.997	0.003
W22.4 Street and highway	0.000	0.997	0.003
W22.0 Home	0.000	0.997	0.003
W22.7 Farm	0.000	0.997	0.003
W22.1 Residential institution	0.000	0.997	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
F43.2 Adjustment disorders	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
E53.8 Deficiency of other specified B group vitamins	0.003	0.997	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.997	0.003
H50.9 Strabismus, unspecified	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.000	0.997	0.003
S36.10 Injury of liver or gallbladder (without open wound into cavity)	0.000	0.997	0.003
W20-W49 Exposure to inanimate mechanical forces	0.000	0.997	0.003
W23.2 School, other institution and public administrative area	0.000	0.997	0.003
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.000	0.997	0.003
I65.8 Occlusion and stenosis of other precerebral artery	0.000	0.997	0.003
W44.0 Home	0.000	0.997	0.003
W44 Foreign body entering into or through eye or natural orifice	0.000	0.997	0.003
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.000	0.997	0.003
J94.8 Other specified pleural conditions	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.4 Other laxatives	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
J94.2 Haemothorax	0.000	0.997	0.003
R60.9 Oedema, unspecified	0.000	0.997	0.003
I65.1 Occlusion and stenosis of basilar artery	0.000	0.997	0.003
W23.3 Sports and athletics area	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.003
W22.5 Trade and service area	0.000	0.997	0.003
J94 Other pleural conditions	0.000	0.997	0.003
I65.0 Occlusion and stenosis of vertebral artery	0.000	0.997	0.003
W49 Exposure to other and unspecified inanimate mechanical forces	0.000	0.997	0.003
A50-A64 Infections with a predominantly sexual mode of transmission	0.003	0.997	0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.003	0.997	0.000
M47.2 Other spondylosis with radiculopathy	0.000	0.997	0.003
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.000	0.997	0.003
J35.0 Chronic tonsillitis	0.000	0.997	0.003
W23.9 Unspecified place	0.000	0.997	0.003
W23.8 Other specified place	0.000	0.997	0.003
W23.6 Industrial and construction area	0.000	0.997	0.003
W23.5 Trade and service area	0.000	0.997	0.003
W23.0 Home	0.000	0.997	0.003
W23.7 Farm	0.000	0.997	0.003
W23.1 Residential institution	0.000	0.997	0.003
T51 Toxic effect of alcohol	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
S36.1 Injury of liver or gallbladder	0.000	0.997	0.003
L29.2 Pruritus vulvae	0.003	0.997	0.000
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
W49.9 Unspecified place	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
Z75.1 Person awaiting admission to adequate facility elsewhere	0.000	0.997	0.003
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T36 Poisoning by systemic antibiotics	0.000	0.997	0.003
W22.09 Striking against or struck by other objects; Home; During unspecified activity	0.000	0.997	0.003
W22.03 Striking against or struck by other objects; Home; While engaged in other types of work	0.000	0.997	0.003
W22.41 Striking against or struck by other objects; Street and highway;While engaged in leisure activity	0.000	0.997	0.003
W22.62 Striking against or struck by other objects; Industrial and construction area ;While working for income	0.000	0.997	0.003
W22.88 Striking against or struck by other objects; Other specified places ;While engaged in other specified activities	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.3 Methadone	0.000	0.997	0.003
T40.1 Heroin	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
W45 Foreign body or object entering through skin	0.000	0.997	0.003
W26 Contact with knife, sword or dagger	0.000	0.997	0.003
T39.0 Salicylates	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.002
T48.5 Anti-common-cold drugs	0.000	0.997	0.002
T48.4 Expectorants	0.000	0.997	0.002
T48.3 Antitussives	0.000	0.997	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.002
T48.0 Oxytocic drugs	0.000	0.997	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.002
T38.7 Androgens and anabolic congeners	0.000	0.997	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.002
T38.5 Other oestrogens and progestogens	0.000	0.997	0.002
T38.4 Oral contraceptives	0.000	0.997	0.002
T38.2 Antithyroid drugs	0.000	0.997	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.002
T63.4 Venom of other arthropods	0.000	0.997	0.003
J94.1 Fibrothorax	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.002
W46 Contact with hypodermic needle	0.000	0.997	0.002
W43 Exposure to vibration	0.000	0.997	0.002
W42 Exposure to noise	0.000	0.997	0.002
W41 Exposure to high-pressure jet	0.000	0.997	0.002
W40 Explosion of other materials	0.000	0.997	0.002
W39 Discharge of firework	0.000	0.997	0.002
W38 Explosion and rupture of other specified pressurised devices	0.000	0.997	0.002
W37 Explosion and rupture of pressurised tyre, pipe or hose	0.000	0.997	0.002
W36 Explosion and rupture of gas cylinder	0.000	0.997	0.002
W35 Explosion and rupture of boiler	0.000	0.997	0.002
W33 Rifle, shotgun and larger firearm discharge	0.000	0.997	0.002
W32 Handgun discharge	0.000	0.997	0.002
W31 Contact with other and unspecified machinery	0.000	0.997	0.002
W30 Contact with agricultural machinery	0.000	0.997	0.002
S36 Injury of intra-abdominal organs	0.000	0.997	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
W44.9 Unspecified place	0.000	0.997	0.002
W44.5 Trade and service area	0.000	0.997	0.002
W44.8 Other specified place	0.000	0.997	0.002
W44.7 Farm	0.000	0.997	0.002
W44.6 Industrial and construction area	0.000	0.997	0.002
W44.4 Street and highway	0.000	0.997	0.002
W44.3 Sports and athletics area	0.000	0.997	0.002
W44.2 School, other institution and public administrative area	0.000	0.997	0.002
W44.1 Residential institution	0.000	0.997	0.002
C09 Malignant neoplasm of tonsil	0.000	0.997	0.003
W20 Struck by thrown, projected or falling object	0.000	0.997	0.002
W34 Discharge from other and unspecified firearms	0.000	0.997	0.002
N64.9 Disorder of breast, unspecified	0.000	0.997	0.002
T40.5 Cocaine	0.000	0.997	0.002
J00 Acute nasopharyngitis [common cold]	0.000	0.997	0.003
S36.00 Injury of spleen (without open wound into cavity)	0.000	0.997	0.002
C02.1 Border of tongue	0.000	0.997	0.002
S36.0 Injury of spleen	0.000	0.997	0.002
N18.0 End-stage renal disease	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.002
W27 Contact with nonpowered hand tool	0.000	0.998	0.002
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.000	0.998	0.002
J94.9 Pleural condition, unspecified	0.000	0.998	0.002
J94.0 Chylous effusion	0.000	0.998	0.002
W29.5 Trade and service area	0.000	0.998	0.002
W49.0 Home	0.000	0.998	0.002
K85.1 Biliary acute pancreatitis	0.000	0.998	0.002
L94.0 Localised scleroderma [morphea]	0.002	0.998	0.000
W29 Contact with other powered hand tools and household machinery	0.000	0.998	0.002
W28 Contact with powered lawn mower	0.000	0.998	0.002
W49.8 Other specified place	0.000	0.998	0.002
W49.7 Farm	0.000	0.998	0.002
W49.5 Trade and service area	0.000	0.998	0.002
W49.4 Street and highway	0.000	0.998	0.002
W49.3 Sports and athletics area	0.000	0.998	0.002
W49.2 School, other institution and public administrative area	0.000	0.998	0.002
W49.1 Residential institution	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
W49.6 Industrial and construction area	0.000	0.998	0.002
A59 Trichomoniasis	0.002	0.998	0.000
A56 Other sexually transmitted chlamydial diseases	0.002	0.998	0.000
A54 Gonococcal infection	0.002	0.998	0.000
A53 Other and unspecified syphilis	0.002	0.998	0.000
A52 Late syphilis	0.002	0.998	0.000
A51 Early syphilis	0.002	0.998	0.000
A50 Congenital syphilis	0.002	0.998	0.000
A64 Unspecified sexually transmitted disease	0.002	0.998	0.000
A58 Granuloma inguinale	0.002	0.998	0.000
A57 Chancroid	0.002	0.998	0.000
A55 Chlamydial lymphogranuloma (venereum)	0.002	0.998	0.000
S36.8 Injury of other intra-abdominal organs	0.000	0.998	0.002
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.000	0.998	0.002
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.000	0.998	0.002
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.000	0.998	0.002
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.000	0.998	0.002
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.000	0.998	0.002
W23.09 Caught, crushed, jammed or pinched in or between objects; Home; During unspecified activity	0.000	0.998	0.002
W23.08 Caught, crushed, jammed or pinched in or between objects; Home; While engaged in other specified activities	0.000	0.998	0.002
W23.03 Caught, crushed, jammed or pinched in or between objects; Home; While engaged in other types of work	0.000	0.998	0.002
W23.52 Caught, crushed, jammed or pinched in or between objects; Trade and service area;While working for income	0.000	0.998	0.002
W23.69 Caught, crushed, jammed or pinched in or between objects; Industrial and construction area ;During unspecified activity	0.000	0.998	0.002
W23.82 Caught, crushed, jammed or pinched in or between objects; Other specified places ;While working for income	0.000	0.998	0.002
W23.99 Caught, crushed, jammed or pinched in or between objects; Unspecified place ;During unspecified activity	0.000	0.998	0.002
W23.92 Caught, crushed, jammed or pinched in or between objects; Unspecified place ;While working for income	0.000	0.998	0.002
W26.8 Other specified place	0.000	0.998	0.002
T51.8 Other alcohols	0.000	0.998	0.002
T51.3 Fusel oil	0.000	0.998	0.002
T51.2 2-Propanol	0.000	0.998	0.002
T51.1 Methanol	0.000	0.998	0.002
S36.11 Injury of liver or gallbladder (with open wound into cavity)	0.000	0.998	0.002
A60 Anogenital herpesviral [herpes simplex] infections	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
T40.2 Other opioids	0.000	0.998	0.002
W45.6 Industrial and construction area	0.000	0.998	0.002
S36.80 Injury of other intra-abdominal organs (without open wound into cavity)	0.000	0.998	0.002
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
I49.4 Other and unspecified premature depolarisation	0.002	0.998	0.000
W45.8 Other specified place	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
T63 Toxic effect of contact with venomous animals	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
W26.9 Unspecified place	0.000	0.998	0.002
W26.5 Trade and service area	0.000	0.998	0.002
W26.0 Home	0.000	0.998	0.002
W26.7 Farm	0.000	0.998	0.002
W26.6 Industrial and construction area	0.000	0.998	0.002
W26.4 Street and highway	0.000	0.998	0.002
W26.3 Sports and athletics area	0.000	0.998	0.002
W26.2 School, other institution and public administrative area	0.000	0.998	0.002
W26.1 Residential institution	0.000	0.998	0.002
W45.9 Unspecified place	0.000	0.998	0.002
W45.0 Home	0.000	0.998	0.002
W45.7 Farm	0.000	0.998	0.002
W45.5 Trade and service area	0.000	0.998	0.002
W45.4 Street and highway	0.000	0.998	0.002
W45.3 Sports and athletics area	0.000	0.998	0.002
W45.2 School, other institution and public administrative area	0.000	0.998	0.002
W45.1 Residential institution	0.000	0.998	0.002
R26.3 Immobility	0.000	0.998	0.002
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.002	0.998	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.000	0.998	0.002
D10.1 Tongue	0.000	0.998	0.002
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
W24 Contact with lifting and transmission devices, not elsewhere classified	0.000	0.998	0.002
C77.3 Axillary and upper limb lymph nodes	0.000	0.998	0.002
K46.9 Unspecified abdominal hernia without obstruction or gangrene	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
M54.37 Sciatica (Lumbosacral region)	0.000	0.998	0.002
W20.0 Home	0.000	0.998	0.002
Z49.1 Extracorporeal dialysis	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
W30.9 Unspecified place	0.000	0.998	0.002
W30.8 Other specified place	0.000	0.998	0.002
W30.7 Farm	0.000	0.998	0.002
W30.6 Industrial and construction area	0.000	0.998	0.002
W30.5 Trade and service area	0.000	0.998	0.002
W30.4 Street and highway	0.000	0.998	0.002
W30.3 Sports and athletics area	0.000	0.998	0.002
W30.2 School, other institution and public administrative area	0.000	0.998	0.002
W30.1 Residential institution	0.000	0.998	0.002
W30.0 Home	0.000	0.998	0.002
W31.9 Unspecified place	0.000	0.998	0.002
W31.8 Other specified place	0.000	0.998	0.002
W31.6 Industrial and construction area	0.000	0.998	0.002
W31.5 Trade and service area	0.000	0.998	0.002
W31.0 Home	0.000	0.998	0.002
W31.7 Farm	0.000	0.998	0.002
W31.4 Street and highway	0.000	0.998	0.002
W31.3 Sports and athletics area	0.000	0.998	0.002
W31.2 School, other institution and public administrative area	0.000	0.998	0.002
W31.1 Residential institution	0.000	0.998	0.002
W32.9 Unspecified place	0.000	0.998	0.002
W32.8 Other specified place	0.000	0.998	0.002
W32.7 Farm	0.000	0.998	0.002
W32.6 Industrial and construction area	0.000	0.998	0.002
W32.5 Trade and service area	0.000	0.998	0.002
W32.4 Street and highway	0.000	0.998	0.002
W32.3 Sports and athletics area	0.000	0.998	0.002
W32.2 School, other institution and public administrative area	0.000	0.998	0.002
W32.1 Residential institution	0.000	0.998	0.002
W32.0 Home	0.000	0.998	0.002
W33.9 Unspecified place	0.000	0.998	0.002
W33.8 Other specified place	0.000	0.998	0.002
W33.7 Farm	0.000	0.998	0.002
W33.6 Industrial and construction area	0.000	0.998	0.002
W33.5 Trade and service area	0.000	0.998	0.002
W33.4 Street and highway	0.000	0.998	0.002
W33.3 Sports and athletics area	0.000	0.998	0.002
W33.2 School, other institution and public administrative area	0.000	0.998	0.002
W33.1 Residential institution	0.000	0.998	0.002
W33.0 Home	0.000	0.998	0.002
W35.9 Unspecified place	0.000	0.998	0.002
W35.8 Other specified place	0.000	0.998	0.002
W35.7 Farm	0.000	0.998	0.002
W35.6 Industrial and construction area	0.000	0.998	0.002
W35.5 Trade and service area	0.000	0.998	0.002
W35.4 Street and highway	0.000	0.998	0.002
W35.3 Sports and athletics area	0.000	0.998	0.002
W35.2 School, other institution and public administrative area	0.000	0.998	0.002
W35.1 Residential institution	0.000	0.998	0.002
W35.0 Home	0.000	0.998	0.002
W36.9 Unspecified place	0.000	0.998	0.002
W36.8 Other specified place	0.000	0.998	0.002
W36.7 Farm	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations